MedPath

The effect of radial extracorporeal shock wave therapy on Peyronie’s disease

Not Applicable
Conditions
Peyronie's disease.
Peyronie disease, Plastic induration of penis
N48.6
Registration Number
IRCT20190108042292N4
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
30
Inclusion Criteria

Age range older than 18 years old
Pain less than 7 in resting and erection according to VAS
Men with full erection

Exclusion Criteria

Drug treatment in three weeks before the intervention
Inability to tolerate pain during radial extracorporeal shock wave treatment
Any surgery or disease in the urinary-genital tract
Psychiatric diseases or psychogenic erectile dysfunction
Neurological disease and lumbar sacral peripheral nerve damage
Penile abnormalities.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Penile plaque dimensions. Timepoint: Before and After the Intervention and one month follow up. Method of measurement: Size of the penile plaque (length, width, circumference, and surface of the plaque) with ultrasonography will be measured.
Secondary Outcome Measures
NameTimeMethod
Sexual function, pain, length and angle of penis. Timepoint: Before and After the intervention and one month follow up. Method of measurement: Sexual function with International index of erectile function questionnaire-5 , pain with visual analogue scale, length of the penis with photography and ruler, angle of penile deviation with photography and goniometer will be measured.
© Copyright 2025. All Rights Reserved by MedPath